Association of GST Genetic Polymorphisms with the Susceptibility to Hepatocellular Carcinoma (HCC) in Chinese Population Evaluated by an Updated Systematic Meta-Analysis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Liu, Kui ^a   Zhang, Lu ^b   Lin, Xialu ^a   Chen, Liangliang ^a   Shi, Hongbo ^a   Magaye, Ruth ^a   Zou, Baobo ^a   Zhao, Jinshun ^a  

^a NINGBO UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CANCER RISK; CHINA; CHINESE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; GSTM1 GENE; GSTT1 GENE; HUMAN; INFORMATION PROCESSING; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; POPULATION GENETICS; RELIABILITY; SENSITIVITY ANALYSIS; SYSTEMATIC ERROR; SYSTEMATIC REVIEW; TAIWAN;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; CHINA; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; LIVER NEOPLASMS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS;

EID: 84874224092     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057043     Document Type: Article

References (70)

1. Cabibbo G, Maida M, Genco C, Antonucci M, Cammà C (2012) Causes of and Prevention Strategies for Hepatocellular Carcinoma; 2012. Elsevier. pp. 374-383.
2. Aghemo A, Colombo M (2012) Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside; Springer. pp. 1-10.
3. French SW, Lee J, Zhong J, Morgan TR, Buslon V, et al. (2012) Alcoholic liver disease-Hepatocellular carcinoma transformation. Journal of Gastrointestinal Oncology 3: 174.
4. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA: a cancer journal for clinicians 59: 225-249.
5. Jemal A, (2010) Center MM, DeSantis C, Ward EM (2010) Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology Biomarkers & Prevention 19: 1893-1907.
6. Annick Buendia M. Genetics of hepatocellular carcinoma; 2000. Elsevier. 185-200.
7. Thorgeirsson SS, Grisham JW, (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nature genetics 31: 339-346.
8. Farazi PA, DePinho RA, (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nature Reviews Cancer 6: 674-687.
9. Wang B, Huang G, Wang D, Li A, Xu Z, et al. (2010) Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. Journal of Hepatology 53: 508-518.
10. Yu L, Wang CY, Xi B, Sun L, Wang RQ, et al. (2011) GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population. World Journal of Gastroenterology: WJG 17: 3248.
11. Chen J, Ma L, Peng NF, Wang SJ, Li LQ (2012) A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population. Molecular Biology Reports: 1-11.
12. Beasley RP, Lin CC, Hwang LY, Chien CS, (1981) Hepatocellular carcinoma and hepatitis B virus. The Lancet 318: 1129-1133.
13. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, et al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proceedings of the National Academy of Sciences 92: 2384-2387.
14. Udomsinprasert R, Pongjaroenkit S, Wongsantichon J, Oakley AJ, Prapanthadara L, et al. (2005) Identification, characterization and structure of a new Delta class glutathione transferase isoenzyme. Biochemical Journal 388: 763.
15. Atkinson HJ, Babbitt PC, (2009) Glutathione transferases are structural and functional outliers in the thioredoxin fold. Biochemistry 48: 11108-11116.
16. Hayes JD, Flanagan JU, Jowsey IR, (2005) Glutathione transferases. Annu Rev Pharmacol Toxicol 45: 51-88.
17. Strange RC, Spiteri MA, Ramachandran S, Fryer AA, (2001) Glutathione-S-transferase family of enzymes. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 482: 21-26.
18. Higgins J, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 21: 1539-1558.
19. Huedo-Medina TB, Sánchez-Meca J, Marín-Martínez F, Botella J, (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychological methods 11: 193.
20. Hedges LV, Vevea JL, (1998) Fixed-and random-effects models in meta-analysis. Psychological methods 3: 486.
21. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics: 1088-1101.
22. Egger M, Smith GD, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
23. Higgins J, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
24. Hsieh LL, Huang RC, Yu MW, Chen CJ, Liaw YF, (1996) L-myc, GST Ml genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers. Cancer Letters 103: 171-176.
25. Bian JC, Wang JB, Wu Y, (1996) Relationship between GSTM1 NULL genotype and genetic susceptibility to primary hepatocellular carcinoma. Chinese Journal of Medical Genetics 13: 353-353.
26. Hu Y, Sheng FM, (1997) Association between GSTM1 gene polymorphism of primary hepatocellular carcinoma and mutation of p53 codon 249. Chinese Journal of Medical Genetics 14: 76-78.
27. Dong CH, Yu SC, Chen GC, Zhao DM, Fu YP, (1997) Polymorphisms of GSTT1 and M1 Genotypes and Their Effects on Elevated Aflatoxin Exposure and Increased Risk of Hepatocellular Carcinoma. Zhong Liu Fang Zhi Yan Jiu 24: 327-329.
28. Dong CH, Yu SZ, Chen GC, Zhao DM, Hu Y, (1998) Association of polymorphisms of glutathione S-transferase M1 and T1 genotypes with elevated aflatoxin and increased risk of primary liver cancer. World Chinese Journal of Digestology 6: 463-466.
29. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, et al. (1999) Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: Independent and interactive effects. American Journal of Epidemiology 149: 621-629.
30. Bian JC, Shen FM, Shen L, Wang TR, Wang XH, et al. (2000) Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1. World Journal of Gastroenterology 6: 228-230.
31. Ma Y, Deng ZL, Wei YP, (2001) Study of the deletion mutation of glutathione S transferase M1 gene and its role in susceptibility to hepatocellular carcinoma. Chinese Journal of Cancer Research 13: 176-178.
32. Wu HL, Cheng ML, Zhang RI, (2000) Relationship Between GSTM1 Gene Polymorphism and Genetic Susceptibility to Primary Hepatocellular Carcinoma. The Practical Journal of Cancer 15: 463-465.
33. Zhu WC, Cheng Q, Luo CL, Chu XW, Wu M, (2001) Relationship Study Between Gene Polymorphism of CYP1A1,GSTM1 and Genetic Susceptibility of Primary Hepatocellar Carcinoma. China J Cancer Prev Treat 8: 572-574.
34. Sun CA, Wang LY, Chen CJ, Lu SN, You SL, et al. (2001) Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: A nested case-control study in Taiwan. Carcinogenesis 22: 1289-1294.
35. Liu CZ, Bian JC, (2002) Genetic Polymorphism of Glutathione S-transferase M 1,T1,P1on Susceptibility Hepatocellular Carcinoma. China Public Health 18: 935-936.
36. Liu ZG, Wei YP, Ma Y, ZL D, (2003) Population with GSTT1 gene deletion and the relationship to hepatocellular carcinoma from guangxi. Journal of Guangxi Medical University 2: 002.
37. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, et al. (2003) Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. Journal of the National Cancer Institute 95: 1485-1488.
38. McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, et al. (2003) Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Research 63: 4594-4601.
39. Li SP, Wu JZ, Ding JH, Gao CM, Cao HX, et al. (2004) Impact of Genetic Polymorphism of Glutathione S-transferase T1,M1 on the Risk of Primary Hepatocellular Carcinoma in Alcohol Drinkers. The Practical Journal of Cancer 19: 229-232.
40. He SJ, Tan JR, Gu YY, Zhong WG, Su SG, (2004) Relationship between Polymorphisms of Phase II Metabolic Genes and the Susceptibility to Hepatocellular Carcinoma in Guangxi. The Practical Journal of Cancer 19: 460-462.
41. Guo HY, Bian JC, Jiang F, Wang QM, Zhang ZM, et al. (2005) The null genotypes of GSTM1 and GSTT1 and the genetic susceptibility of primary liver cancer in Luoyang,China. Tumor Jan 25: 58-61.
42. Ma DL, Chen YX, Li Y, Zhao HT, Xie XM, et al. (2005) Glutathione-S-transferase M1 and T1 polymorphisms and susceptibility to liver cancer in hepatitis B surface antigen positive population. Medical Journal of the Chinese People's Armed Police 27: 656-657.
43. Long XD, Ma Y, Wei YP, Deng ZL, (2005) Study on the detoxication gene gstM1-gstT1-null and susceptibility to aflatoxin B1 related hepatocellular carcinoma in Guangxi. Chinese Journal of Epidemiology 26: 777-781.
44. Deng ZL, Wei YP, Ma Y, (2005) Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China. World Journal of Gastroenterology 11: 272-274.
45. Long XD, Ma Y, Wei YP, Deng ZL, (2006) The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatology Research 36: 48-55.
46. Yang ZG, Xie YA, Kuang ZP, Luo XL, Zhang WM, et al. (2009) Relationship between genetic polymorphisms of glutathione-s-transferase M1,T1 genes and susceptibility to hepatocellular carcinoma in population of Fusui District of Guangxi Zhuang Autonomous Region. Chinese Journal of Cancer Prevention and Treatment 16: 970-973.
47. Kao CC, Chen MUK, Kuo WUH, Chen TY, Su SC, et al. (2010) Influence of glutathione-S-transferase theta (GSTT1) and mu (GSTM1) gene polymorphisms on the susceptibility of hepatocellular carcinoma in Taiwan. Journal of Surgical Oncology 102: 301-307.
48. Wei Y, Long X, Liu Z, Ma Y, Deng Z, (2012) Genetic polymorphism of glutathione-S-transferase M1 and T1 in associated with carcinogenesis of hepatocellular carcinoma and nasopharyngeal carcinoma. Chinese-German Journal of Clinical Oncology 11: 138-141.
49. Tang YT, Li XP, Liu TQ, Yang JR, Luo JQ, et al. (2012) A study of genetic polymorphisms of Glutathione S-transferase in patients with hepatocellular carcinoma. Chin J Lab Diagn 16.
50. Li CG, Zhao ZM, Hu MG, et al. (2012) Predictive Role of Glutathione-S-transferase Gene Polymorphisms in Risk and Prognosis of Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention 13: 3247-3252.
51. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, et al. (2005) Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. International Journal of Epidemiology 34: 1310-1318.
52. Zhang YC, Deng CS, Zhu YQ, (2005) Study on genetic polymorphisms of xenobiotica metabolizing enzymes in hepatitis B virus- associated hepatic disease. Wenzhou Yi Xue Yuan Xue Bao 35: 464-467.
53. Zhu MH, Chen XH, Zhou LF, (2005) Association of genetic polymorphisms in glutathione S-transferases M1 with hepatitis beta-related hepatocellular carcinoma. Journal of Zhejiang University (Medical Sciences) 34: 126-130.
54. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, et al. (1996) Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis 17: 1855-1859.
55. Wang J, Deng Y, Cheng J, Ding J, Tokudome S, (2003) GST genetic polymorphisms and lung adenocarcinoma susceptibility in a Chinese population. Cancer Letters 201: 185.
56. Helzlsouer KJ, Huang HY, Hoffman S, Alberg AJ, Comstock GW, et al. (1998) Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. Journal of the National Cancer Institute 90: 512-518.
57. Zhong S, Wyllie A, Barnes D, Wolf C, Spurr N, (1993) Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis 14: 1821-1824.
58. Deng CH, Zi XL, (1997) Relationship between Deletion of Slutathion S-trausferase Gene and Susceptibility to Primary Hepatocellular Carcinoma. Chinese Journal of Public Health 16: 141-142.
59. Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, et al. (1995) Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology 109: 1266-1273.
60. Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, et al. (1996) Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. American Journal of Human Genetics 59: 128.
61. Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, et al. (1997) Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. Journal of Hepatology 27: 320-330.
62. Bian J, Shen F, Wang J, Chen G, Zhang B, et al. (1999) The mutation of deletion for glutathione S-transferase M1 gene in the tissue of hepatocellular carcinoma. Chinese Journal of Medical Genetics 16: 171-173.
63. Sun C, Wu D, Wang L, Chen C, You S, et al. (2002) Determinants of formation of aflatoxin-albumin adducts: a seven-township study in Taiwan. British Journal of Cancer 87: 966-970.
64. He S, (2005) the analysis of GSTM1,GSTT1 gene polymorphism in HCC. Joural of Guangxi Medical University 22: 875-877.
65. He SJ, Gu YH, M ZH, (2007) Effect of interaction between smoking, alcohol drinking and polymorphisms of phase II metabolic genes on the susceptibility of hepatocellular carcinoma. Basic Medical Sciences and Clinics 27: 666-669.
66. He SJ, Gu YH, M ZH (2008) The association between GSTM1 gene polymorphism and wine,tobacco habit and susceptibility in primary liver cancer. Journal of Guangxi Medical Unversity 25.
67. Long X, Ma Y, Wei Y, Deng ZL, (2005) A study about the association of detoxication gene GSTM1 polymorphism and the susceptibility to aflatoxin B1-related hepatocellular carcinoma. Chinese Journal of Hepatology 13: 668.
68. Deng Z, Wei Y, Ma Y, (2001) Glutathione-S-transferase M1 genotype in patients with hepatocellular carcinoma. Chinese Journal of Oncology 23: 477-479.
69. Wei YP, Ma Y, Deng ZL, (2004) Genetic polymorphisms of Glutathione S-transferase M1 and T1 and the risk of hepatocellular carcinoma. Tumor 23: 464-466.
70. Wei YP, Long XD, Liu CZ, Ma Y, Deng ZL, (2010) Genetic polymorphism of glutathione-S-transferase M1 and T1 in associated with carcinogenesis of hepatocellular carcinoma and nasopharyngeal carcinoma. Cancer Research On Prevention And Treatment 37: 1162-1165.